112 related articles for article (PubMed ID: 8305630)
21. Urinary excretion of p-hydroxylated methamphetamine metabolites in man. I. A method for determination by high-performance liquid chromatography-electrochemistry.
Shimosato K; Tomita M; Ijiri I
Arch Toxicol; 1986 Oct; 59(3):135-40. PubMed ID: 3813878
[TBL] [Abstract][Full Text] [Related]
22. Identification of the main urinary metabolites of omeprazole after an oral dose to rats and dogs.
Hoffmann KJ
Drug Metab Dispos; 1986; 14(3):341-8. PubMed ID: 2872036
[TBL] [Abstract][Full Text] [Related]
23. Maternal-fetal pharmacokinetics of methanol.
Pollack GM; Brouwer KL
Res Rep Health Eff Inst; 1996 Jun; (74):1-48; discussion 49-53. PubMed ID: 11381741
[TBL] [Abstract][Full Text] [Related]
24. Biotransformation of aryl alkylamines by Cunninghamella bainieri.
Foster BC; Coutts RT; Pasutto FM
Xenobiotica; 1989 May; 19(5):531-8. PubMed ID: 2750209
[TBL] [Abstract][Full Text] [Related]
25. Studies on Para-Methoxymethamphetamine (PMMA) Metabolite Pattern and Influence of CYP2D6 Genetics in Human Liver Microsomes and Authentic Samples from Fatal PMMA Intoxications.
Vevelstad M; Øiestad EL; Nerem E; Arnestad M; Bogen IL
Drug Metab Dispos; 2017 Dec; 45(12):1326-1335. PubMed ID: 28978661
[TBL] [Abstract][Full Text] [Related]
26. Biotransformation of cerivastatin in mice, rats, and dogs in vivo.
Boberg M; Angerbauer R; Kanhai WK; Karl W; Kern A; Radtke M; Steinke W
Drug Metab Dispos; 1998 Jul; 26(7):640-52. PubMed ID: 9660846
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of the antianxiety drug buspirone in human subjects.
Jajoo HK; Mayol RF; LaBudde JA; Blair IA
Drug Metab Dispos; 1989; 17(6):634-40. PubMed ID: 2575499
[TBL] [Abstract][Full Text] [Related]
28. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J
Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829
[TBL] [Abstract][Full Text] [Related]
29. Excretion and biotransformation of cisapride in dogs and humans after oral administration.
Meuldermans W; Van Peer A; Hendrickx J; Lauwers W; Swysen E; Bockx M; Woestenborghs R; Heykants J
Drug Metab Dispos; 1988; 16(3):403-9. PubMed ID: 2900732
[TBL] [Abstract][Full Text] [Related]
30. Toxicokinetics and biotransformation of 3-(4-methylbenzylidene)camphor in rats after oral administration.
Völkel W; Colnot T; Schauer UM; Broschard TH; Dekant W
Toxicol Appl Pharmacol; 2006 Oct; 216(2):331-8. PubMed ID: 16806338
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacokinetic study of rifampicin in the body of pregnant animals].
Subbotina NA; Griaznov NS; Beliavskaia IV; Chugunova VI; Sazykin IuO
Antibiotiki; 1979 Sep; 24(9):687-91. PubMed ID: 485120
[TBL] [Abstract][Full Text] [Related]
32. Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy.
Colizza K; Awad M; Kamel A
Drug Metab Dispos; 2007 Jun; 35(6):884-97. PubMed ID: 17360832
[TBL] [Abstract][Full Text] [Related]
33. Biotransformation of the antipsychotic agent, mazapertine, in dog--mass spectral characterization and identification of metabolites.
Wu WN; McKown LA; Takacs AR; Jones WJ; Reitz AB
Xenobiotica; 1999 May; 29(5):453-66. PubMed ID: 10379984
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the biotransformation pathways of clomiphene, tamoxifen and toremifene as assessed by LC-MS/(MS) following in vitro and excretion studies.
Mazzarino M; Biava M; de la Torre X; Fiacco I; Botrè F
Anal Bioanal Chem; 2013 Jun; 405(16):5467-87. PubMed ID: 23604525
[TBL] [Abstract][Full Text] [Related]
35. Quantitative determination of the urinary excretion of ketobemidone and four of its metabolites after intravenous and oral administration in man.
Bondesson U; Hartvig P; Danielsson B
Drug Metab Dispos; 1981; 9(4):376-80. PubMed ID: 6114838
[TBL] [Abstract][Full Text] [Related]
36. [Effect of bonafton on the bodies of pregnant animals].
Proĭnova VA; Shashkina LF; Nechushkina LV; Fedorova EA
Farmakol Toksikol; 1980; 43(3):337-42. PubMed ID: 7449974
[TBL] [Abstract][Full Text] [Related]
37. Blood pressure and heart rate response evoked by p-hydroxyamphetamine and by p-hydroxynorephedrine II. A quantitative assessment of the role of amphetamine metabolites in acute responses evoked by d-amphetamine.
Simpson LL
J Pharmacol Exp Ther; 1980 Jun; 213(3):504-8. PubMed ID: 7205614
[TBL] [Abstract][Full Text] [Related]
38. Excretion and metabolism of the antihypertensive agent, RWJ-26240 (McN-5691) in dogs.
Wu WN; Masucci JA; Caldwell GW; Carson JR
Drug Metab Dispos; 1998 Feb; 26(2):115-25. PubMed ID: 9456297
[TBL] [Abstract][Full Text] [Related]
39. Biotransformation and elimination of 14C-flecainide acetate in humans.
McQuinn RL; Quarfoth GJ; Johnson JD; Banitt EH; Pathre SV; Chang SF; Ober RE; Conard GJ
Drug Metab Dispos; 1984; 12(4):414-20. PubMed ID: 6148206
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of carvedilol in dogs, rats, and mice.
Schaefer WH; Politowski J; Hwang B; Dixon F; Goalwin A; Gutzait L; Anderson K; DeBrosse C; Bean M; Rhodes GR
Drug Metab Dispos; 1998 Oct; 26(10):958-69. PubMed ID: 9763400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
